Surmodics (STU:SU6) Total Stockholders Equity : €114.0 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Surmodics Total Stockholders Equity?

Surmodics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €114.0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Surmodics's Book Value per Share for the quarter that ended in Mar. 2024 was €8.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Surmodics's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.27.

Surmodics Total Stockholders Equity Historical Data

The historical data trend for Surmodics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surmodics Total Stockholders Equity Chart

Surmodics Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Total Stockholders Equity

Get a 7-Day Free Trial

111.25

111.27

119.07

109.48

112.36

Surmodics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															95.79	103.76	112.36	112.01	114.03

Surmodics (STU:SU6) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Surmodics's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(114.034	-	0)	/	14.26
	=	8.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Surmodics's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.921	+	30.047)	/	114.034
	=	0.27

Surmodics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Surmodics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Surmodics (STU:SU6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surmodics Inc (STU:SU6) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

SRDX:USA SU6:Germany

Address

9924 West 74th Street, Eden Prairie, MN, USA, 55344

Website

https://www.surmodics.com

Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.

Surmodics (STU:SU6) Headlines

No Headlines